19 completed, 4 unknown, 2 recruiting, 2 terminated. 28 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 28 | Completed 19, Unknown 4, Recruiting 2, Terminated 2, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Chorionic Gonadotropin: new trials by email Literature Review of Chorionic Gonadotropin trials Research Report on Chorionic Gonadotropin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST) Human chorionic gonadotropin (hCG), Follitropin delta, Triptorelin - Low Ovarian Reserve, Poor Ovarian Response | Phase 3 | Recruiting | Fundación para la Investigación del Hospital Clínico de Valencia | 126 | 2024-09-17 | 2026-09-11 |
| Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome Anastrozole, Semaglutide, human chorionic gonadotropin - Klinefelter Syndrome | Phase 3 | Recruiting | Georgios Papadakis | 150 | 2023-03-21 | 2026-05-11 |
| Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction Oxytocin, Human Chorionic Gonadotropin - Ovulation Induction, Polycystic Ovary Syndrome | Phase 3 | Completed | Shakeela Ishrat | 60 | 2023-01-01 | 2025-08-29 |
| COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES 10000 IU hCG (Choriomon5000 IU; IBSA), Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring) - Infertility | Phase 3 | Unknown | Alexandria University | 160 | 2022-06-01 | 2022-05-31 |
| Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders Duphaston, Gonadotropin, Cetrotide Injectable Product - Infertility, Female | Phase 3 | Completed | El Shatby University Hospital for Obstetrics and Gynecology | 90 | 2020-09-01 | 2022-02-17 |
| Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders Dual trigger, hCG (standard) - Poor Ovarian Reserve | Phase 3 | Completed | American University of Beirut Medical Center | 140 | 2018-07-11 | 2021-07-23 |
| Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART hCG, Placebo - HCG; IVF; Pregnancy Rates; ART; Chorionic Gonadotropin | Phase 3 | Terminated | National and Kapodistrian University of Athens | 80 | 2018-06-01 | 2021-03-30 |
| Triggering of Follicular Maturation Recombinant Human Chorionic Gonadotrophin, human chorionic gonadotrophin + gonadotrophin releasing hormone agonist - Increase Pregnancy Rate | Phase 3 | Completed | Assiut University | 160 | 2016-11-01 | 2019-03-20 |
| Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles hCG (Ovitrelle 250 mcg mcg - Merck Serono), hCG (Ovitrelle 250 mcg mcg - Merck Serono) + GnRH agonist (Decapeptyl 0.2mg - Ferring Gmgh) - In-vitro Fertilization | Phase 3 | Unknown | Tel-Aviv Sourasky Medical Center | 1000 | 2016-09-01 | 2016-08-11 |
| A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation highly purified human chorionic gonadotropin, recombinant human chorionic gonadotropin - Infertility | Phase 3 | Completed | Ferring Pharmaceuticals | 176 | 2016-04-01 | 2019-06-26 |
| Human Chorionic Gonadotrophin & Trigger Human chorionic gonadotrophin, clomiphene citrate alone - Ovulation Disorder | Phase 3 | Unknown | Cairo University | 200 | 2014-10-01 | 2017-02-08 |
| Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility Human chorionic gonadotropin, FSH co-trigger, Letrozole - Unexplained Infertility | Phase 3 | Completed | Benha University | 108 | 2014-06-01 | 2016-05-19 |
| An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029) MK-8962, recFSH, Ganirelix - Infertility | Phase 3 | Withdrawn | Organon and Co | 2014-03-01 | 2022-02-03 | |
| Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART) Pergoveris®, GONAL-f®, Recombinant human chorionic gonadotrophin (r-hCG) - Infertility | Phase 3 | Completed | Merck KGaA, Darmstadt, Germany | 939 | 2014-01-31 | 2017-08-24 |
| Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response. Ganirelix 0.25 mg., Recombinant choriogonadotropin alfa, Micronized natural progesterone. - Infertility | Phase 3 | Completed | Instituto de Investigacion Sanitaria La Fe | 234 | 2013-09-01 | 2017-06-12 |
| Human Chorionic Gonadotrophin in an Antagonist Protocol Low dose HCG, Placebo - Infertility | Phase 2 / Phase 3 | Completed | Cairo University | 60 | 2013-08-01 | 2015-02-03 |
| Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel COL-1620, Gonadotropin-releasing hormone (GnRH) analogue, Follicle-stimulating hormone (FSH) - Luteal Hormone Supplementation in In-vitro Fertilization, Embryo Transfer | Phase 3 | Completed | Merck KGaA, Darmstadt, Germany | 178 | 2013-07-01 | 2015-12-21 |
| Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women MSJ-0011, urinary hCG (u-hCG), Follitropin alpha - Anovulation, Oligo-ovulation | Phase 3 | Completed | Merck KGaA, Darmstadt, Germany | 81 | 2012-09-01 | 2016-01-07 |
| A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique GONAL-f®, Luveris®, Recombinant human chorionic gonadotropin (r-hCG) - Infertility, Fertility | Phase 3 | Terminated | Merck KGaA, Darmstadt, Germany | 174 | 2012-05-01 | 2015-11-09 |
| Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS) Dexamethasone, recombinant human chorionic gonadotropin (r-hCG) - PCOS | Phase 3 | Completed | University of California, San Diego | 24 | 2011-08-01 | 2019-04-30 |
Showing 20 of 28. Sign in to see all of them.
Infertility (11) · Polycystic Ovary Syndrome (4) · Helping Behavior (3) · Anovulation (1) · Hypogonadism (1) · Infertility, Female (1) · Klinefelter Syndrome (1) · Menstruation Disturbances (1) · Metabolic Syndrome (1) · Oligomenorrhea (1)
Merck KGaA, Darmstadt, Germany (8) · Cairo University (2) · Organon and Co (2) · University of California, San Diego (2) · Alexandria University (1) · American University of Beirut Medical Center (1) · Assiut University (1) · Benha University (1) · El Shatby University Hospital for Obstetrics and Gynecology (1) · Ferring Pharmaceuticals (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · Georgios Papadakis (1) · Instituto de Investigacion Sanitaria La Fe (1) · National and Kapodistrian University of Athens (1) · Royan Institute (1)
Egypt (4) · China (2) · France (2) · Germany (2) · Greece (2) · Japan (2) · Spain (2) · United States (2) · Bangladesh (1) · Belgium (1) · Brazil (1) · Denmark (1) · Finland (1) · Iran (1) · Italy (1)
Ahmed Walid Anwar Murad, MD (1) · Aly A Hussein, Ass.lecturer (1) · Beni Almog, professor (1) · Cesar Lizan Tudela (1) · Charalampos Siristatidis, Ass Prof (1) · Ghina S Ghazeeri, MD (1) · Hamid Gourabi, PhD (1) · Huafei Li (1) · Mervat Sh EL-Arab, MDPhD (1)
PMID 19684043, PMID 19719843, PMID 19825188, PMID 20843746, PMID 21270326, PMID 22866896, PMID 23274511, PMID 23543584, PMID 23758821, PMID 24188875, PMID 24903202, PMID 25303490, PMID 25313914, PMID 26141305, PMID 26194884, PMID 26950065, PMID 26991902, PMID 27473350, PMID 27619773, PMID 28137754
2004 (1), 2016 (1)